Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
WuXi PharmaTech, China's largest...
WuXi Healthcare Ventures, the investment...
WuXi PharmaTech has formed a partnership...
WuXi PharmaTech and Eli Lilly will...
AstraZeneca announced plans to invest $800 million in...
WuXi PharmaTech, China's largest...
WuXi AppTec, China's largest CRO/CMO,...
WuXi AppTec reported that Shanghai...
WuXi AppTec, China's largest CRO/CMO,...
In a major cross-border deal, WuXi...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China